NM Flashcards
PET –> how does it work?
1) radiotracer –> emit positron –> travel small distance in tissue
2) meet electron –> positron & electron annihilate
3) create two 511 keV photons –> travel 180 deg apart
PET –> what radiotracer?
Fluorine-18 fluorodeoxyglucose (F-18 FDG)
PET –> F-18 FDG –> MOA?
glucose analog –> GLUT1 & 3 -> transport into cells –> phosphorylated by hexokinase –> trapped in cell
F-18 –> half life?
110 min
standardized uptake value (SUV) –> proportional to what formula?
(ROI activity x body wt) / administered activity
PET: FDG uptake –> depend on what lab values?
serum glucose & insulin levels
PET: inc insulin –> what happen to FDG uptake?
inc uptake by muscle –> dec sensitivity for mild FGD-avid lesions
PET: how long NPO?
at least 4hr –> insulin at basal level
PET: blood glucose level should be?
<200 –> prefer
PET: inject F-18 FDG –> rest in quiet room –> how long?
1hr
PET –> effect of metformin?
- inc colonic uptake
- small inc small bowel uptake
PET: salivary gland, tonsil, thyroid –> normal uptake?
symm –> mild-mod uptake
PET: bowel –> normal uptake?
diffuse –> mild-mod uptake
PET: heart –> normal uptake?
variable
PET: muscle –> normal uptake?
- usu low
- if elevated insulin –> inc uptake
- if recent exercise –> inc uptake
PET: brown fat –> normal uptake? exacerbating factor?
mild-mod
cold
brown fat –> MC location?
- supraclavicular
- intercostal
PET/CT –> evaluate what type of lung cancer? why?
only non-small cell lung cancer
small cell –> considered metastatic at dx
LN staging –> gold standard?
mediastinoscopy
PET –> malig LN –> sens? spec?
- very sens
- not spec
pulm nodule –> smallest size that can be eval by PET?
8 mm
solitary pulm nodule –> not FDG avid –> next step?
short term f/u
solitary pulm nodule –> FDG avid –> next step?
- bx
- resect
colon CA –> role of PET?
- local colon cancer –> limited role
- good for mets eval
colon CA –> initial tx –> when can do f/u PET? why?
2mo
peritx period –> inc FDG uptake –> flare phenomenon
head/neck CA –> tx –> when can do f/u PET? why?
4mo
chemorad –> alter anatomy, inflamm –> dec specificity for recurrent dz
inc thyroglobulin –> whole body radioiodine scan –> neg –> next step?
PET –> look for thyroid CA:
- undiff
- medullary
PET –> lymphoma –> inc marrow uptake –> diffuse –> ddx? (3)
- granulocyte colony-stimulating factor (G-CSF)
- ctx –> rebound effect
- malig marrow infiltration
esophagus CA –> role of PET?
ID mets –> not surg candidate
esophagus CA –> initial neoadjuvant tx –> dec FDG avid by how much –> favorable prognosis?
at least 30%
esophagus CA –> initial neoadjuvant tx –> unchanged FDG avid –> indicates what in terms of tx?
ctx ineffective –> stop ctx
cancers w limited role for PET? (4)
- HCC
- RCC
- bladder CA
- prostate
HCC –> limited role for PET –> why?
high phosphatase –> dephosphorylate FDG –> FDG diffuse out of cells
bladder CA –> limited role for PET –> why?
surrounding high urine FDG uptake
LV perfusion imaging –> evaluates what?
blood flow to myocardium
LV perfusion imaging –> perfusion abnormality –> factors to eval? (5)
- ir/reversible?
- size?
- severity: mild (subendocardial), mod, severe (transmural)?
- coronary A territory?
- assoc abnormalities? –> RV uptake, ischemia dilation, wall motion abnormal?
LV perfusion imaging –> stress –> 3 methods?
- physical –> treadmill
- pharmacologic-adrenergic –> dobutamine
- pharmacologic-vasodilatory –> dipyridamole, adenosine
myocardial perfusion imaging –> indications? (6)
- eval acute chest pain
- eval hemodynamic significance of coronary stenosis
- risk stratification after MI
- preoperative risk assessmt for noncardiac surg
- eval viability prior to revasc therapy
- eval myocardial revasc s/p CABG
risk stratification after MI –> myocardial perfusion imaging –> “high risk” findings? (5)
- sig peri-infarct ischemia
- defect in diff vascular territory –> mult-vessel dz
- sig lung uptake –> LV dysfx
- LV aneurysm
- low EF <40%
what is “hibernating” myocardium?
myocardium:
- hypoperfused
- viable
myocardial viability imaging –> 2 methods?
- # 1 F-18 FDG PET
- thallium-201 perfusion imaging
myocardium –> region of perfusion defect –> FDG uptake –> dx? tx?
viable myocardium –> CABG or percutaneous intervention
myocardium –> region of perfusion defect –> no FDG uptake –> dx?
non-viable scar –> medical therapy only
radionuclides used in nuclear cardiology? (5)
- thallium-201
- technetium-99m sestamibi (cardiolite)
- rubidium-82
- nitrogen-13 ammonia
- F-18 FDG
thallium-201:
- half life?
- decay?
- charact Xray?
- MOA?
- 73hr
- electron capture
- 69-81 keV
- potassium analog –> ATP-dep Na-K transmembrane pump –> into cell –> uptake directly proportional to myocardial perfusion
thallium-201 –> myocardial perfusion imaging –> max exercise –> perfusion defect –> at least what % stenosis?
50%
thallium-201 –> undergoes redistribution –> T/F?
T
technetium-99m sestamibi (cardiolite) –> undergoes redistribution –> T/F?
F
technetium-99m sestamibi (cardiolite) –> MOA?
passive diffusion –> into cell –> bind to mitochondrial membrane proteins –> uptake proportional to myocardial perfusion
rubidium-82:
- half life?
- decay?
- MOA?
- perfusion vs viability?
- 76 sec
- positron
- potassium analog
- perfusion
rubidium-82 –> type of stress –> exercise vs pharmacologic –> why?
pharm only –> very short half life
nitrogen-13 ammonia:
- half life?
- decay?
- perfusion vs viability?
- 10min
- positron
- perfusion
myocardial imaging –> nitrogen-13 ammonia –> pro (2) vs con (2)?
pro:
- don’t travel far in tissue –> high resolution
- short half-life –> can give lrg dose
con:
- short half life –> must be produced by cyclotron on-site
- pharm stress only
F-18 FDG:
- half life?
- decay?
- perfusion vs viability?
- 110 min
- positron
- viability only –> must correlate w sestamibi perfusion study
myocardial perfusion study:
- NPO how long? why?
- should stop what meds? why?
NPO 6hr –> dec splanchnic blood flow –> reduce liver/bowel uptake
hold CCB/BB –> allow to reach target HR
myocardial perfusion study –> stress –> max heart rate? target heart rate?
max HR = 220 bpm - age
target HR = 85% of max HR
myocardial perfusion study –> dipyridamole –> MOA?
adenosine deaminase inh –> adenosine accumulate –> vasodilate –> coronary blood flow inc 3-5x
myocardial perfusion study –> dipyridamole –> what subst must be held for 24hr prior to study? (2) why?
- theophylline
- caffeine
reverse effects of dipyridamole
myocardial perfusion study –> dipyridamole –> antidote?
aminophylline
myocardial perfusion study –> differentiate: dipyridamole vs adenosine (3)
adenosine:
- same effect as dipyridamole
- faster effect
- very short half life –> no reversal agent required
myocardial perfusion study –> regadenoson –> MOA? pro compared to adenosine?
adenosine receptor agonist –> vasodilate
easier to administer than adenosine
myocardial perfusion study –> dobutamine –> MOA?
B1 agonist –> inc myocardial O2 demand
myocardial perfusion study –> dobutamine –> indication?
adenosine contraindicated:
- severe asthma
- COPD
- recent caffeine
Tc-99m sestamibi perfusion study –> when image after injection (min)? why?
30min after inject –> allow liver activity to clear
Tc-99m sestamibi perfusion study –> gated SPECT show wall motion at time of what? perfusion imaging shows perfusion at time of what?
gated SPECT –> wall motion at time of imaging
perfusion imaging –> perfusion at time of inject
cardiac imaging –> Tc-99m sestamibi perfusion study vs PET perfusion –> which has grter sens, spec, accuracy?
PET perfusion
myocardial imaging –> significant RV uptake –> ddx? (2)
- R heart dz
- pHTN
myocardial imaging –> pulm uptake –> ddx? (1)
LV dysfx
myocardial imaging –> stress –> LV dilate –> ddx? (1)
transient ischemic dilation (TID) –> 3-vessel dz (even if no focal defect)
myocardial imaging –> what is a small perfusion defect? med? large?
- small: 1-2 segmts
- med: 3-4
- lrg: >5
myocardial imaging –> fixed perfusion defect –> ddx? (2)
- myocardial scar
- hibernating myocardium
LV –> vertical vs horizontal long axis –> U-shape point in which direction?
- vertical: U to the left
- horizontal: U point down
I-131:
- half life?
- decay?
- how produced?
- 8day
- beta particles & gamma photon (364 keV)
- generator
I-131 –> use?
therapy only:
- thyroid cancer s/p thyroidectomy
- hyperthyroid (Graves, multinodular goiter)
I-123:
- half life?
- decay?
- how produced?
- mode of administration?
- 13hr
- electron capture & gamma photon (159 keV)
- cyclotron
- PO
I-123 –> use?
thyroid imaging
thyroid –> radiotracers? (3)
- I-131
- I-123
- Tc-99m pertechnetate
Tc-99m pertechnetate:
- half life?
- decay?
- mode of administration?
- 6hr
- gamma photon (140 keV)
- IV
thyroid radiotracers –> ok during pregnancy? why?
no –> cross placenta –> taken up by fetus
when can resume breastfeeding?
- I-131
- I-123
- Tc-99m
- I-131: never
- I-123: 2-3 days after administration
- Tc-99m: 12-24hr
I-131/I-123 therapy/imaging –> patient pre-procedure prep? why?
non-suppressed TSH (high TSH level):
- stop exogenous thyroid hormone for 4wk
- 2 IM injection of TSH
inc thyroid uptake of radiotracer
ectopic thyroid tissue –> 3 types?
- lingual thyroid
- retrosternal thyroid (substernal goiter)
- ovarian teratoma (struma ovarii)
ectopic thyroid tissue –> imaging options? (2)
- I-123
- Tc-99m
thyroid nodule –> cytology indeterminate –> next step?
nuclear imaging
thyroid nodule –> hyperfxing –> ddx? (1)
benign adenoma
thyroid nodule –> cold –> ddx? (2)
- 70-75% benign colloid cyst
- 20% malig
thyroid nodule –> warm –> ddx? (1)
cold nodule –> overlapping thyroid tissue
thyroid nodule –> warm –> next step?
oblique view –> still indeterminate –> bx
what is discordant thyroid nodule? next step?
- Tc-99m –> hot –> can uptake technetium
- I-123 –> cold –> can’t trap iodine
may be malig –> bx
thyroid imaging –> normal 6hr uptake? 24hr?
- 6hr –> 6-18%
- 24hr –> 10-30%
Graves dz –> thyroid imaging –> dec/normal/inc?
- 6hr uptake
- 24hr
- 6hr –> elevated
- 24hr –> elevated
thyroid imaging –> how can differentiate if I-123 vs Tc-99m?
Tc-99m –> salivary uptake
Graves dz –> how can differentiate if I-123 vs Tc-99m?
often not possible –> thyroid uptake too strong –> salivary glands often not seen
Graves dz –> definitive tx? MC?
- # 1 I-131
- surg
MC inflamm dz of thyroid?
Hashimoto thyroiditis
Hashimoto thyroiditis -> thyroid scan –> appearance?
- diffuse inc activity (like Graves)
- patchy uptake (like MNG)
subacute thyroiditis –> thyroid imaging –> dec/normal/inc?
- 6hr uptake
- 24hr
- 6hr –> dec
- 24hr –> slight inc
thyroid cancer –> thyroidectomy –> 1-2mo later –> I-131 tx –> goal?
image + trt:
- residual dz
- potential mets
I-131 –> low dose (<30 mCi) vs high dose (100-200) –> indication?
low risk pt –> low dose:
- <1.5 cm
- no invasion of thyroid capsule
risk high –> high dose
thyroid cancer –> s/p I-131 ablation –> monitor?
follow thyroglobulin levels
thyroid cancer –> s/p I-131 ablation –> inc thyroglobulin –> next step?
I-123 scan –> assess for dz recurrence/mets
thyroid cancer –> s/p I-131 ablation –> inc thyroglobulin –> I-123 scan positive –> next step?
repeat I-131 ablation
thyroid cancer –> s/p I-131 ablation –> CI to monitor with thyroglobulin levels?
presence of anti-thyroglobulin Ab
Graves dz –> I-131 tx –> CI? (3)
- preg
- lactation
- unable to comply w radiation safety guidelines
I-131 tx –> Graves dz vs multinodular goiter –> # of tx?
- Graves –> single dose
- MNG: mult tx may be required
parathyroid imaging –> radiotracer?
Tc-99 sestamibi
nuclear imaging –> parathyroid –> indication?
localize suspected parathyroid adenoma
nuclear imaging –> parathyroid adenoma –> findings?
- early phase: inc uptake
- delayed phase: persistent retained activity
nuclear imaging –> thyroid adenoma –> findings?
- early phase: inc uptake
- delayed phase: washout
Tc-99m sulfur colloid –> uptake by what tissues?
reticuloendothelial cells:
- # 1 liver –> Kupffer cells
- # 2 spleen
- # 3 BM
Tc-99m sulfur colloid:
- Tc-99m physical half life?
- sulfur colloid biologic half life?
- Tc-99m: 6hr
- sulfur colloid: 2-3min
sulfur colloid scan –> what is photopenic defect? MCC?
complete absence of radiotracer
hepatic cyst
sulfur colloid scan –> focal dec uptake –> ddx? (3)
most hep mass:
- HCC
- adenoma
- abscess
sulfur colloid scan –> focal inc uptake –> ddx? (3)
- focal nodular hyperplasia
- liver cirrhosis –> regenerating nodule
- Budd-Chiari (hep V thrombosis) –> late stage –> inc uptake in caudate lobe
sulfur colloid scan –> what is colloid shift? ddx? (1)
spleen & BM –> inc sulfur colloid
liver dysfx –> #1 cirrhosis
sulfur colloid scan –> diffuse pulm uptake –> ddx? (4)
nonspecific:
- cirrhosis
- COPD w infx
- Langerhans cell histiocytosis
- high aluminum (antacids, excess Al in colloid preparation)
sulfur colloid scan –> focal nodular hyperplasia (FNH) –> appearance? (3)
- normal liver (contain Kupffer cells)
- inc uptake (Kupffer cells + hypervasc)
- photopenic defect (insuff colloid concentration)
focal nodular hyperplasia (FNH) –> nuclear imaging options? (2)
- sulfur colloid scan
- HIDA
focal nodular hyperplasia (FNH) –> HIDA finding?
contain bile ductules –> positive on HIDA
intra-pancreatic spleen –> nuclear imaging options? (2)
- sulfur colloid scan
- Tc-99m damaged red cell study
GI bleed –> nuclear imaging options? (2)
- Tc-99m labeled RBCs
- Tc-99m sulfur colloid
GI bleed –> Tc-99m sulfur colloid study –> cons? (2)
- sig prep time
- vasc half-life 2-3min –> rapid blood clearance
GI bleed –> Tc-99m labeled RBCs study –> in vitro vs in vivo –> which is more commonly used? why?
1 in vitro –> 95% labeling efficiency
in vivo –> worse labeling eff –> free pertechnetate –> noisier images
GI bleed –> tagged RBC study vs IR angiography –> can detect bleeding rate of?
- tagged RBC: 0.2 ml/min
- IR angio: 1 ml/min
GI bleed –> tagged RBC study –> appearance?
activity –> over time –> peristalsis of intraluminal blood –> change shape & position
Tc-99m pertechnetate –> localize to what tissue?
gastric mucosa
Meckel diverticulum –> radiotracer?
Tc-99m pertechnetate